India’s medical research sector has reached an important milestone as the Indian Council of Medical Research (ICMR) has completed 100 successful technology transfer agreements, helping move homegrown scientific innovations closer to practical use. The development is expected to strengthen cooperation between research institutions and Indian companies while supporting the growth of healthcare innovation.
The announcement was made during the third Department of Health Research–ICMR Health Research Excellence Summit at Bharat Mandapam in New Delhi. The two-day event brought together more than 600 scientists, researchers, innovators, administrators and policymakers from across the country.
Eight Technologies Covered Under 20 New Agreements
During the summit, ICMR exchanged 20 licensing agreements covering eight technologies with nine Indian companies. This took the total number of successful technology transfer deals to 100 in less than two years under the Medical Innovations Patent Mitra initiative, launched in March 2025.
The event also featured an exhibition showcasing 17 technologies developed by ICMR institutes and research partners. Additionally, 10 technologies and eight patents were presented during a dedicated session highlighting India’s growing medical research capabilities.
Three New Initiatives Announced
The summit also introduced three initiatives aimed at strengthening the country’s healthcare research system.
- Research to Action Vertical: Designed to convert scientific findings into practical information for government policies and healthcare programmes.
- Syndromic Surveillance Network: An early-warning system for detecting possible disease outbreaks through 70 Virus Research and Diagnostic Laboratories and Infectious Disease Research and Diagnostic Laboratories.
- Dr M K Bhan Young Medical Faculty PhD Portal: A centralised digital platform providing information to prospective applicants.
Focus on Better Disease Surveillance
ICMR also released its Annual Report on Antimicrobial Resistance along with standard operating procedures to improve consistency in laboratory testing and research.
The summit marked 115 years of ICMR’s contribution to biomedical research in India. It highlighted how partnerships between scientists, government institutions and private companies can help turn laboratory research into useful healthcare solutions.
What This Means for India’s Healthcare Sector
The 100 technology transfer milestone represents progress in connecting Indian research with industry. Greater collaboration could support the development and wider availability of indigenous medical technologies.
The new surveillance initiative may also strengthen the country’s ability to identify potential disease outbreaks earlier, while the research-to-policy programme aims to make scientific evidence more useful in public healthcare planning.
